Browse our extensive catalog of high-quality chemicals for research and development.
| Product Name | Description | CAS Number | Molecular Formula | Molecular Weight | Description |
|---|---|---|---|---|---|
| 2-Deoxy-1,N6-dimethyladenosine | NA | C12H17N5O3 | 279.3 | ||
| 4-Deoxy-4-fluoro-D-mannose | 87764-47-4 | C6H11FO5 | 182.15 | ||
| 5-Deoxy-5-fluoro-N-[(2-methylbutoxy)carbonyl]cytidine | Capecitabine EP Impurity D | 910129-15-6 | C15H22FN3O6 | 359.35 | Capecitabine EP Impurity D
|
| 5-Deoxy-5-fluoro-N-[(3-methylbutoxy)carbonyl]cytidine | [1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl]-carbamic Acid 3-Methylbutyl Ester; 5-Deoxy-5-fluoro-N4-(isopentyloxycarbonyl)cytidine; Capecitabine EP Impurity E | 162204-30-0 | C15H22FN3O6 | 359.35 | [1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl]-carbamic Acid 3-Methylbutyl Ester; 5-Deoxy-5-fluoro-N4-(isopentyloxycarbon... |
| (2R)​-2-​Deoxy-​2-​fluoro-​2-​methyl-uridine 5-​Triphosphate Triethylammonium Salt | Sofosbuvir Impurity; RO 2433 Triphosphate Triethylammonium Salt | NA | C28H61FN5O14P3 | 803.73 | Sofosbuvir Impurity; RO 2433 Triphosphate Triethylammonium Salt
|
| 5-Bromo-N-methylnicotinamide | 153435-68-8 | C7H7BrN2O | 215.05 | ||
| 4-Deoxy-4-fluoro-1,2,3,6-tetra-O-benzoyl-alpha-D-mannose | 1309463-38-4 | C34H27FO9 | 598.57 | ||
| 2-Bromo-4-methylpentanoic Acid Methyl Ester | 2-Bromo-4-methylpentanoic Acid Methyl Ester; Methyl 2-bromo-4-methylpentanoate; Methyl 2-bromo-4-methylvalerate; Methyl α-bromoisocaproate; | 61837-46-5 | C7H13BrO2 | 209.08 | 2-Bromo-4-methylpentanoic Acid Methyl Ester; Methyl 2-bromo-4-methylpentanoate; Methyl 2-bromo-4-methylvalerate; Methyl α-bromoisocaproate;
|
| 6-Bromo-N-methylnicotinamide | 869640-48-2 | C7H7BrN2O | 215.05 | ||
| 2-Deoxy-2-fluoro-5-iodocytidine | 1563: PN: US6617438 TABLE: 1 claimed sequence | 80791-93-1 | C9H11FIN3O4 | 371.1 | 1563: PN: US6617438 TABLE: 1 claimed sequence
|
Page 2145 of 10017